Fatty Acid Metabolism Reprogramming in Advanced Prostate Cancer
Prostate cancer (PCa) is a carcinoma in which fatty acids are abundant. Fatty acid metabolism is rewired during PCa development. Although PCa can be treated with hormone therapy, after prolonged treatment, castration-resistant prostate cancer can develop and can lead to increased mortality. Changes...
Main Authors: | Huan Xu, Yanbo Chen, Meng Gu, Chong Liu, Qi Chen, Ming Zhan, Zhong Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-11-01
|
Series: | Metabolites |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-1989/11/11/765 |
Similar Items
-
Reprogramming hormone-sensitive prostate cancer to a lethal neuroendocrine cancer lineage by mitochondrial pyruvate carrier (MPC)
by: Huan Xu, et al.
Published: (2022-05-01) -
Mechanisms of castration resistant prostate cancer formation and progression through neuroendocrine differentiation
by: Xueping Ma, et al.
Published: (2021-09-01) -
The Current Therapeutic Landscape for Metastatic Prostate Cancer
by: Anastasia Bernal, et al.
Published: (2024-03-01) -
Undesirable Status of Prostate Cancer Cells after Intensive Inhibition of AR Signaling: Post-AR Era of CRPC Treatment
by: Tomoyuki Makino, et al.
Published: (2021-04-01) -
Metabolic Reprogramming and Predominance of Solute Carrier Genes during Acquired Enzalutamide Resistance in Prostate Cancer
by: Shiv Verma, et al.
Published: (2020-11-01)